Drug companies and publishers set out 10 steps to enhance credibility of industry sponsored trials

BMJ 2012; 344 doi: http://dx.doi.org/10.1136/bmj.e3767 (Published 28 May 2012)
Cite this as: BMJ 2012;344:e3767

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

  1. Bob Roehr
  1. 1Washington, DC

A coalition of drug companies and major medical journal publishers has recommended 10 steps to help refurbish the tarnished credibility and enhance the quality and transparency of the reporting of industry sponsored clinical trials. The 10 steps were published in the May issue of the Mayo Clinic Proceedings.1

The Medical Publishing Insights and Practices Initiative (MPIP) was established in 2008 by leading drug companies and medical publishers as an ongoing collaboration (www.mpip-initiative.org). The recommendations grew out of a meeting held in New York in November 2010.

The initiative’s first recommendation is that research should be grounded in the asking and answering of questions …

Get access to this article and all of bmj.com for the next 14 days

Sign up for a 14 day free trial today

Access to the full text of this article requires a subscription or payment. Please log in or subscribe below.

Article access

Article access for 1 day

Purchase this article for £20 $30 €32*

The PDF version can be downloaded as your personal record

* Prices do not include VAT

THIS WEEK'S POLL